相关实验视频

Updated: May 7, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

电脑识别潜在的管氨基激酶1 (TTBK1) 抑制剂:一种结构模拟方法

Kaathambari Purushothaman¹, Esaimozhi Sivasankar¹, Monika Krishnamoorthy¹

¹School of BioSciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu 632014 India.

In silico pharmacology

|July 25, 2024

概括

这项研究确定了一个潜在的新药候选者,CID70794974,以向陶素激酶1 (TTBK1) 治疗神经退行性疾病,如阿尔茨海默氏症. 这种化合物在计算模型中显示出抑制蛋白聚合的前景.

科学领域:

神经科学是一个神经科学.
计算化学的计算化学
药物发现药物发现药物发现

背景情况:

大脑中的异常蛋白质聚合 (α-synuclein,tau) 会导致神经退行性疾病.
蛋白的高酸化和聚合导致神经纤维状,破坏神经元的结构和功能.
陶素激酶1 (TTBK1) 是陶过酸化中的关键酶,也是潜在的治疗点.

研究的目的:

通过基于结构的虚拟查来识别管素激酶1 (TTBK1) 的新型抑制剂.
评估潜在的TTBK1抑制剂在神经退行性疾病中的治疗疗效.
以计算方式选可抑制蛋白聚合的化合物.

主要方法:

基于结构的虚拟选3884个化合物对TTBK1.1.
使用数据战士和瑞士ADME应用利宾斯基规则用于药物相似性和ADMET过.
分子对接 (Autodock Vina,Autodock 4.2),分子动力学模拟 (Gromacs,VMD) 和蛋白质 - 连接体相互作用分析.

主要成果:

2772种化合物通过了最初的药物相似性过器.
计算分析发现CID70794974是一个有前途的打击化合物,针对TTBK1.
分子动力学模拟证实了CID70794974-TTBK1复合物的稳定性和相互作用概况.

结论:

CID70794974是通过抑制TTBK1.1.通过抑制神经退行性疾病的潜在治疗.
需要进一步的实验验证,以确认CID70794974在阿尔茨海默病模型中的有效性.
这项研究强调了虚拟查在发现神经系统疾病新型激酶抑制剂方面的实用性.

关键词:

分子对接是分子对接.分子模拟分子模拟神经退行性疾病神经退行性疾病寻找相似性的搜索陶氏蛋白质是一种陶氏蛋白质.

更多相关视频

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

相关概念视频

Allosteric Proteins-ATCase

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...